PROLIFICA - West African Treatment Cohort for Hepatitis B

NCT02129829 · clinicaltrials.gov ↗

COMPLETED

Status

1079

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic
Hepatocellular Carcinoma

Interventions

DRUG: Tenofovir disoproxil

Sponsor

Imperial College London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]